Clinical and economic burden of pneumococcal disease in older US adults
- 1 July 2010
- journal article
- Published by Elsevier BV in Vaccine
- Vol. 28 (31), 4955-4960
- https://doi.org/10.1016/j.vaccine.2010.05.030
Abstract
No abstract availableKeywords
This publication has 28 references indexed in Scilit:
- A Prediction Rule for Estimating the Risk of Bacteremia in Patients with Community‐Acquired PneumoniaClinical Infectious Diseases, 2009
- Alternative strategies for adult pneumococcal polysaccharide vaccination: A cost-effectiveness analysisVaccine, 2008
- Incidence of Pneumococcal Disease Due to Non–Pneumococcal Conjugate Vaccine (PCV7) Serotypes in the United States during the Era of Widespread PCV7 Vaccination, 1998–2004The Journal of Infectious Diseases, 2007
- Etiologic Diagnosis of Adult Bacterial Pneumonia by Culture and PCR Applied to Respiratory Tract SamplesJournal of Clinical Microbiology, 2006
- The Influence of Chronic Illnesses on the Incidence of Invasive Pneumococcal Disease in AdultsThe Journal of Infectious Diseases, 2005
- Microbiological profile of community-acquired pneumonia in adults over the last 20 yearsJournal of Infection, 2005
- Microbiological etiology in clinically diagnosed community-acquired pneumonia in primary care in Örebro, SwedenClinical Microbiology & Infection, 2003
- Microbial Etiology of Community-Acquired Pneumonia in the Adult Population of 4 Municipalities in Eastern FinlandClinical Infectious Diseases, 2001
- Study of community acquired pneumonia aetiology (SCAPA) in adults admitted to hospital: implications for management guidelinesThorax, 2001
- Efficacy of Pneumococcal Vaccine in High-Risk PatientsNew England Journal of Medicine, 1986